Harbor Capital Advisors’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.83M	Buy	33,948 +3,375	+11%	+$267K	0.23%	114
2025 Q4	$2.38M	Buy	30,573 +645	+2%	+$43.6K	0.18%	144
2025 Q3	$1.69M	Sell	29,928 -3,544	-11%	-$160K	0.13%	206
2025 Q2	$1.46M	Buy	33,472 +2,594	+8%	+$89.3K	0.06%	377
2025 Q1	$845K	Sell	30,878 -10,109	-25%	-$369K	0.04%	461
2024 Q4	$1.65M	Buy	40,987 +684	+2%	+$30.9K	0.07%	346
2024 Q3	$1.91M	Buy	40,303 +9,292	+30%	+$410K	0.08%	309
2024 Q2	$926K	Sell	31,011 -10,321	-25%	-$357K	0.07%	378
2024 Q1	$1.66M	Buy	41,332 +6,691	+19%	+$239K	0.22%	110
2023 Q4	$882K	Sell	34,641 -570	-2%	-$10.2K	0.17%	155
2023 Q3	$489K	Buy	35,211 +3,834	+12%	+$77.1K	0.1%	231
2023 Q2	$721K	Buy	31,377 +20,059	+177%	+$575K	0.14%	185
2023 Q1	$335K	Sell	11,318 -360	-3%	-$11.6K	0.1%	175
2022 Q4	$291K	Sell	11,678 -247	-2%	-$6.59K	0.28%	73
2022 Q3	$260K	Sell	11,925 -340	-3%	-$8.96K	0.24%	77
2022 Q2	$241K	Sell	12,265 -1,730	-12%	-$40.4K	0.18%	79
2022 Q1	$592K	Sell	13,995 -2,856	-17%	-$121K	0.28%	75
2021 Q4	$1.07M	Buy	+16,851	New	+$981K	0.39%	69